Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
Epidermal Growth Factor Receptor Expression in Triple Negative and Nontriple Negative Breast Carcinomas ; volume:7 ; number:02 ; year:2015 ; pages:079-083
Journal of laboratory physicians ; 7, Heft 02 (2015), 079-083
- Beteiligte Personen und Organisationen
-
Changavi, Arathi A.
Shashikala, Arundhathi
Ramji, Ashwini S.
- DOI
-
10.4103/0974-2727.163129
- URN
-
urn:nbn:de:101:1-2020062506251381230880
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Changavi, Arathi A.
- Shashikala, Arundhathi
- Ramji, Ashwini S.
Ähnliche Objekte (12)
Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China
Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters
Histological analysis of [gamma][delta] T lymphocytes infiltrating human triple-negative breast carcinomas
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
ZMIZ2 promotes the development of triple-receptor negative breast cancer
Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses
Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer
Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China
Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters
Histological analysis of [gamma][delta] T lymphocytes infiltrating human triple-negative breast carcinomas
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
ZMIZ2 promotes the development of triple-receptor negative breast cancer
Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses
Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers
Metabotropic glutamate receptor-1 regulates inflammation in triple negative breast cancer
Oxidative stress and counteracting mechanisms in hormone receptor positive, triple-negative and basal-like breast carcinomas
Lack of epidermal growth factor receptor (EGFR)-activating mutations in triple-negative breast cancer in China
Epidermal growth factor receptor (EGFR) overexpression in triple-negative breast cancer: association with clinicopathologic features and prognostic parameters
Histological analysis of [gamma][delta] T lymphocytes infiltrating human triple-negative breast carcinomas
Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas
Mutations in the epidermal growth factor receptor (EGFR) gene in triple negative breast cancer: possible implications for targeted therapy
Activation of mammalian target of rapamycin (mTOR) in triple negative feline mammary carcinomas
ZMIZ2 promotes the development of triple-receptor negative breast cancer
Immune environment of high-TIL breast cancer: triple negative and hormone receptor positive HER2 negative
Triple-negative breast carcinomas of low malignant potential: review on diagnostic criteria and differential diagnoses
Frequently increased epidermal growth factor receptor (EGFR) copy numbers and decreased BRCA1 mRNA expression in Japanese triple-negative breast cancers